5-amino-1mq nnmt inhibitor study obesity — 50mg | (NAD+ Axis) 5-Amino-1MQ 50mg (60 Capsules)
Description
Best published PK (Awosemo et al., 2021, rats): ~38% oral bioavailability, ~6 to 7 hr oral half-life
rotating sites helps
Someone who struggles with hunger and cravings may find compounds like cagrilintide or semaglutide more helpful than 5-amino-1mq alone
Anyone pregnant, breastfeeding, or with a diagnosed metabolic, hepatic, or endocrine condition falls entirely outside any studied context and should not be a subject of self-directed use
